Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) shares passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $6.01 and traded as low as $0.60. Nemus Bioscience shares last traded at $0.65, with a volume of 1,004,500 shares traded.
Nemus Bioscience Stock Performance
The firm has a 50 day moving average price of $6.01 and a 200 day moving average price of $4.96.
About Nemus Bioscience
Nemus Bioscience, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; NB1222 used for treating chemotherapy induced nausea and vomiting; and NB3111 for the treatment of methicillin-resistant staphylococcus aureus.
See Also
- Five stocks we like better than Nemus Bioscience
- Stock Dividend Cuts Happen Are You Ready?
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Brinker International Offers a Pullback Opportunity on EPS Miss
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
